Post-myocardial Infarction (MI) Care: Medication Adherence for Secondary Prevention After MI in a Large Real-world Population-Reference-Cited by-同舟云学术

Post-myocardial Infarction (MI) Care: Medication Adherence for Secondary Prevention After MI in a Large Real-world Population

Published:2019-01 Issue:1 Volume:41 Page:107-117
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Huber Carola A.,Meyer Matthias R.,Steffel Jan,Blozik Eva,Reich Oliver,Rosemann Thomas

Funder

Amgen

AstraZeneca

Boehringer-Ingelheim

Bristol-Myers Squibb

Cook Medical

Novartis

Pfizer

Sanofi-Aventis

Sorin

Zoll

Ownership of CorXL

Atricure

Bayer Healthcare

Biosense Webster

Boston Scientific

Daiichi-Sankyo

Medtronic

St. Jude Medical/Abbott

Biotronik

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference29 articles.

1. Cardiovascular disease in Europe: epidemiological update 2016;Townsend;Eur Heart J,2016

2. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

3. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

4. Survival after hospital discharge for ST-segment elevation and non-ST-segment elevation acute myocardial infarction: a population-based study;Darling;Clin Epidemiol,2013

5. Prognostic models for stable coronary artery disease based on electronic health record cohort of 102 023 patients;Rapsomaniki;Eur Heart J,2014

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The relationship of cardiovascular disease risk, clozapine antipsychotic use and cognitive function in a large Chinese schizophrenia cohort;Brain Research;2024-12

2. Care Gaps and System Issues With Delivering Cardiovascular Risk Reduction and Lipid-Lowering Therapy in Secondary Prevention;Canadian Journal of Cardiology;2024-08

3. Adherence to optimal medical therapy and control of cardiovascular risk factors in patients after ST elevation myocardial infarction in Mexico;Frontiers in Cardiovascular Medicine;2024-07-23

4. Electronic medical information and analytical system (EMIAS) as a tool for the new level of understanding and diagnosis of medication adherence in patients with myocardial infarction in primary care practice in Moscow;Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice;2024-07-02

5. Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) scientific statement on the simplification of the drug regimen for secondary cardiovascular prevention;European Heart Journal Supplements;2024-04